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Abstract
Introduction: Tackling health inequities both within and between countries remains high on the agenda of international
organizations including the World Health Organization and local, regional and national governments. Systematic reviews
can be a useful tool to assess effects on equity in health status because they include studies conducted in a variety of
settings and populations. This study aims to describe the extent to which the impacts of health interventions on equity in
health status are considered in systematic reviews, describe methods used, and assess the implications of their equity
related findings for policy, practice and research.
Methods: We conducted a methodology study of equity assessment in systematic reviews. Two independent reviewers
extracted information on the reporting and analysis of impacts of health interventions on equity in health status in a group
of 300 systematic reviews collected from all systematic reviews indexed in one month of MEDLINE, using a pre-tested data
collection form. Any differences in data extraction were resolved by discussion.
Results: Of the 300 systematic reviews, 224 assessed the effectiveness of interventions on health outcomes. Of these 224
reviews, 29 systematic reviews assessed effects on equity in health status using subgroup analysis or targeted analyses of
vulnerable populations. Of these, seven conducted subgroup analyses related to health equity which were reported in
insufficient detail to judge their credibility. Of these 29 reviews, 18 described implications for policy and practice based on
assessment of effects on health equity.
Conclusion: The quality and completeness of reporting should be enhanced as a priority, because without this policymakers
and practitioners will continue lack the evidence base they need to inform decision-making about health inequity.
Furthermore, there is a need to develop methods to systematically consider impacts on equity in health status that is
currently lacking in systematic reviews.
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Introduction
Health inequities have been defined as unfair and avoidable
inequalities in health across socioeconomic, demographic and
geographic factors [1]. Specific population groups have been
identified as ‘‘vulnerable’’ to health inequities. This vulnerability in
turn is linked to social systems that differentially distribute
resources across sociodemographic strata such as gender, socio-
economic position, and ethnicity. Health inequity exists both
within and between countries. For example, under five childhood
mortality is less than 6 per 1000 births in industrialized countries
compared to 160 per 1000 in sub-Saharan Africa [2]. Within low
and middle income countries (LMIC), under-five mortality is a
median of two times higher in the poorest people compared to the
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highest wealth quintile. Within high income countries, health
inequalities also exist. For example, Aboriginal people in Canada
have 5 years lower life expectancy than non-Aboriginals [3].
We have shown with the Equity Effectiveness Loop framework
that the effectiveness of clinical and public health interventions may
be reduced by up to two thirds in vulnerable populations. This is
due to a ‘‘staircase’’ effect due to lower coverage, worse screening,
poor provider compliance and lower consumer adherence [4].
Because of this staircase effect, interventions may have the
unintended adverse effect of increasing inequity in health status.
Decision-makers are increasingly under public pressure to
consider the effects of programs and policies on health equity
[5,6]. There is increasing acceptance that systematic reviews can
inform policy and practice since they reduce the chance of being
misled, increase confidence in results, are an efficient use of time
and are more easy to critically appraise and apply [7,8].
Systematic reviews also represent an opportunity to identify what
works to reduce health inequity [5]. However, decision-makers cite
lack of evidence on impacts of health interventions on equity as a
major barrier to using systematic reviews for evidence-informed
decision-making [9,10].
We have a moral obligation to ensure that clinical and public
health interventions help the disadvantaged, but all too often
interventions justified in the name of the poor benefit the most
advantaged people, not the poorest [11]. NICE in the UK has
taken a leadership role in insisting that equity evidence is needed
to inform decisions about the likely impacts of clinical and public
health interventions in different population groups. Specifically,
the 2009 NICE Public Health methods guidance asks ‘‘How does
effectiveness and cost-effectiveness vary according to the age,
gender, class and ethnicity of the target audience? Is there any
differential impact on inequalities in health within and between
different population groups?’’ [2]. Furthermore, the World Health
Organization Commission on Social Determinants of Health and
Campbell and Cochrane Equity methods group have proposed
that more attention on health equity in systematic reviews could
increase relevance for policy and clinical practice [12].
Despite this need to assess the evidence on impacts of health
interventions on equity in health status, systematic reviews rarely
assess whether interventions have an impact on health equity[13].
Furthermore, our Cochrane review of methods found that none of
the included studies had assessed the credibility of subgroup
analyses nor the importance of equity assessment for the
implications for practice and policy [14]. Lack of credibility and
failure to discuss implications are a substantial barrier in using
systematic reviews for policy and practice decisions.
This methodology study aimed to describe the extent to which
impacts of health interventions on equity in health status are
considered in systematic reviews, describe methods used, assess
their credibility and assess the implications of their equity-related
findings for policy, practice and research.
The specific objectives were to: 1) Evaluate definitions of health
equity in systematic reviews; 2) Assess methods used by systematic
reviews to assess impacts of health interventions on equity in health
status; 3) Assess subgroup analyses according to seven credibility
criteria; and 4) Assess implications of equity findings on conclusions.
Methods
Ethical approval was not required for this study.
Definition of health equity
As above, health equity is defined as unfair and avoidable health
differences [1]. The acronym PROGRESS-Plus defines socio-
demographic factors across which differences in effectiveness of
interventions could be considered inequitable [15,16]: Place of
residence; Race/ethnicity/culture; Occupation; Gender/sex; Reli-
gion; Education; Socioeconomic status; Social capital. The ‘‘Plus’’
was proposed to promote the inclusion of additional factors across
which disadvantage may exist due to discrimination and other
reasons such as age, sexual orientation and disability [17].
Differences in health status outcomes across PROGRESS-Plus
were considered differences in equity in health status if they were
classified as inequitable or unfair by the authors of the systematic
review, or they met the Whitehead criteria for inequity in health
[1].
Study design
This study is designed as a methodology study, defined by the
Cochrane Methodology Review group as: ‘‘a study of the methods used
in randomized trials, other healthcare evaluations or systematic reviews. Data
for methodology studies can come from clinical studies, such as randomized
trials, epidemiological studies, from participants in a new study, or from
systematic reviews of clinical studies’’ [18].
This study assessed the methods used in systematic reviews of
effectiveness to consider effects on health equity.
Data source
We selected all systematic reviews indexed on MEDLINE in
one month (November 2004) because the characteristics of these
systematic reviews were already well described by Moher et al
[19], and we wanted a group of greater than 100 systematic
reviews with a diversity of health conditions and interventions
since we expected less than 10% of systematic reviews would assess
effects on health equity. We previously found that there was no
increase in equity analyses over time in systematic reviews between
2004 and 2008 (unpublished data).
This group of systematic reviews was assembled using Montori’s
empirical search terms for high sensitivity (.98%) in retrieval of
systematic reviews [20]. The search was run on February 18, 2005,
with the terms: (1) 200411$.ed; (2) limit 1 to English (3) 2 and
(cochrane database of systematic reviews.jn. or search.tw. or
metaanalysis.pt. or medline.tw. or systematic review.tw. or
((metaanalysis.mp,pt. or review.pt. or search$.tw.) and method-
s.ab.)). Two reviewers screened the titles and abstracts, then a
single reviewer screened the full-text to identify articles which met
the following definition for a systematic review: ‘‘the authors stated
objective was to summarize evidence from multiple studies and the
article described explicit methods’’ [19]. A second reviewer
independently screened a random sample of 10% of the full-text
reviews. The search was limited to English-language due to
resource implications of including non-English articles [19]. There
is no evidence from two previous studies that non-English
language papers are likely to assess impacts on equity in health
status differently or more frequently [13,21]. The search retrieved
300 systematic reviews.
For the purpose of this methodology study on health equity,
systematic reviews were included if the stated purpose was to assess
the effects of an intervention on health outcomes. Adhering to this
criterion resulted in the exclusion of 76 of the 300 systematic
reviews. Reasons for exclusion fell into two main categories. Either
the study did not assess the effectiveness of an intervention on
health outcomes or the study was not concerned with health
outcomes (e.g. focused on literacy instead of health).
Data extraction for this study
Two reviewers (two of BD, EU, VW, MBJ) independently
extracted data on reporting and analysis of differences in
Health Equity and Systematic Reviews
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effectiveness across PROGRESS-Plus factors, using a pre-tested
data extraction form. This data extraction form included 51 items
on the characteristics of the population, intervention, comparison
(setting), outcomes and study design (i.e. randomized controlled
trials, observational studies or both), whether health inequalities or
health inequities were described and how they were defined.
Subgroup analysis across PROGRESS-Plus was assessed, using
the definition in the Cochrane Handbook: ‘‘Subgroup analyses
involve splitting all the participant data into subgroups, often so as
to make comparisons between them. Subgroup analyses may be
done for subsets of participants (such as males and females), or for
subsets of studies (such as different geographical locations)’’ [22].
Extraction by two independent extractors was compared and
differences were resolved by discussion. There were few discrep-
ancies between data extractors.
Objective 1. We assessed whether health equity or health
inequalities were defined and described in the systematic reviews.
We looked for any description of how health equity was defined
such as whether differences were avoidable or unfair, whether
proxy measures were used (such as receipt of health insurance for
the poor) and how the judgment of fairness or avoidability was
made. We expected such definitions only for those reviews where
the review intended to assess effects on health equity across one or
more PROGRESS-Plus factor.
Objective 2. We assessed the methods used by systematic
reviews to assess impacts of health interventions on equity in
health status
Objective 3. Subgroup analyses conducted across
PROGRESS-Plus factors were assessed according to the seven
‘credibility’ criteria for subgroup analysis, proposed by Oxman
and Guyatt [23], that are in the Cochrane Handbook of
Systematic Reviews [22]. These credibility criteria are intended
to minimize the over-interpretation of spurious differences: 1.
Clinically important difference? 2. Statistically significant
difference? 3. A priori hypothesis? 4. Subgroup analysis one of
small number of hypotheses tested? 5. Difference suggested by
comparisons within studies? 6. Difference consistent across studies?
7. Indirect evidence that supports hypothesized difference?
Objective 4. We assessed whether differences in equity in
health status across PROGRESS-PLUS factors were described in
the discussion section and the implications for research and practice.
Results
Characteristics of included systematic reviews
Of the group of 300 systematic reviews, 224 were classified as
assessing the effects of an intervention on health outcomes (web
appendix S1). Of the 76 systematic reviews that were excluded, 16
assessed test characteristics of diagnostic methods, 21 conducted
systematic reviews of research methods (e.g. quality assessment)
and 39 assessed the association of patients’ characteristics with
outcomes.
Of the 224 included systematic reviews, 153 (68%) described the
characteristics of the populations in the primary studies across one
or more PROGRESS-Plus characteristics as follows: gender/sex
(49%), age (47%), place of residence (22%), and LMIC setting
(9%) were most frequently reported (Table 1), followed by race/
ethnicity/culture (4%), socioeconomic status (3%), occupation
(1%), education (1%) and social capital (1%).
Objective 1: Definition of health inequalities
No reviews explicitly mentioned health equity. A small
proportion (18/224) did describe in the background or discussion
section that one or more PROGRESS-Plus factors were
hypothesized to modify the impact of interventions. These 18
systematic reviews stated that health status differences across
PROGRESS-Plus factors have been hypothesized elsewhere to
affect the effectiveness of interventions, but none of these
systematic reviews attached the term ‘‘health inequity’’ to these
Table 1. PROGRESS-Plus factors described in 224 systematic reviews.
Population described by
PROGRESS -Plus
Theory considers
PROGRESS-Plus
Analysis of differences
across PROGRESS-Plus
(using qualitative,
quantitative or targeted
methods)
Applicability or
implications consider
PROGRESS-Plus
68%
(153/224)
8%
(18/224)
12%
(29/224)
21%
(49/224)
Overall 153 18 29 49
Place 49 2 0 1
Race/ethnicity 10 4 2 9
Occupation 2 0 0 1
Gender/sex 109 3 9 11
Religion 0 0 1 0
Education 2 2 1 3
Socioeconomic status 6 3 7 7
Social capital 2 2 4 5
LMIC 21 3 3 15
Disability 3 3 3 13
Age 105 2 2 1
PROGRESS-Plus: Place of residence (including urban/rural); Race/ethnicity/culture, Occupation, Gender, Religion, Education, Socioeconomic status, Social capital; Plus
includes age, disability and low and middle income country (LMIC).
Note: PROGRESS-Plus items add up to more than the overall because some systematic reviews assessed more than one PROGRESS-Plus factor.
doi:10.1371/journal.pone.0031360.t001
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differences, nor hinted at this concept by describing these
differences in health as unfair and avoidable.
Objective 2: Methods used to assess differences in effects
across PROGRESS-Plus equity determining variables
Of 224 systematic reviews, 29 assessed differences in effects
across PROGRESS-Plus variables, using explicit methods of
subgroup analysis (n = 15) or targeted analysis of vulnerable
populations (n = 14) (Web appendix S2). None of the reviews used
a gradient approach, defined as assessing differences in health
across the whole range of a measure of disadvantage such as across
income levels or grades of socioeconomic position, thus recogniz-
ing a systematic pattern of worsening health outcomes with greater
disadvantage [24] Nine of these 29 systematic reviews described
health inequalities which were hypothesized to influence the
effectiveness of interventions.
Of these 29 systematic reviews, 24 found differences in effects of
interventions on health or social outcomes across PROGRESS-
Plus variables.
Objective 3: Assess subgroup analyses according to
seven credibility criteria for subgroup analyses
Subgroup analyses were classified into two types: 1) pooled, and
2) description of within-study differences. Seven systematic reviews
compared pooled results from more than one study using statistical
methods. Eight systematic reviews described differences in effects
across one or more PROGRESS-Plus factor within individual
studies, without combining data.
a) Pooled results (n=7 systematic reviews). Seven
systematic reviews assessed impacts of health interventions on
equity in health status using subgroup analysis. These subgroup
analyses met a median of three out of the seven credibility criteria
(min-max 2–5) (Table 2). These seven systematic reviews assessed
differences in relative effects (n = 2) and absolute effects (n = 5).
Only one of these seven systematic reviews found a statistically
significant difference; between studies of educational interventions
which reported the gender ratio and those that did not [25].
According to the authors of the systematic review, this result may
be related to lack of reporting rather than true differences between
boys and girls [25].
b) Description of within-study differences without
pooling (n= 8). Eight systematic reviews described differences
in effects across PROGRESS-Plus characteristics observed within
individual studies (Web Appendix S2). These systematic reviews
described the effects within individual studies across gender/sex
(n = 7), socioeconomic status (n = 3), education (n= 1), occupation
(n= 1), religion (n= 1) and age (n= 2).
Objective 4: Influence of considering health equity on
conclusions
Of those 29 reviews which evaluated effects on equity in health
status, 18 (62%) described implications for policy, practice or
research (Web Appendix S2).
Discussion
This study of 224 systematic reviews is the largest study of equity
assessment in a random sample of systematic reviews, and it is the
first study to assess the reporting of subgroup analyses related to
vulnerable populations using explicit criteria and to assess the
influence of equity analyses on the implications and conclusions of
reviews. This study found that subgroup analyses were not
reported in sufficient detail to judge their credibility. Secondly,
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this study found that equity results influenced the implications for
two thirds of reviews.
We found that 13% of systematic reviews assessed effects of
interventions in vulnerable populations using either subgroup
analysis or targeted approaches, and 68% of systematic reviews
described the population according to one or more PROGRESS-
Plus factor. We propose that description of populations for some
characteristics of PROGRESS-Plus, such as age and sex, is
necessary to adhere to reporting standards and does not imply an
equity perspective. However, some characteristics such as
socioeconomic status and low and middle income country setting
may indeed suggest an equity perspective is taken, and this would
increase the proportion of systematic reviews with an equity
perspective to higher than 13%.
None of the systematic reviews assessed whether effects were
different across a gradient of disadvantage. None of the systematic
reviews used the term ‘‘health equity’’ or described differences in
effects as unfair. This is not necessarily undesirable and may reflect
uncertainty about the normative judgment of fairness in different
settings. For those systematic reviews that conducted subgroup
analysis, the methods for reporting them met only three out of
seven criteria for assigning credibility to a subgroup analysis [23].
This study has a number of strengths. We performed double
extraction with verification and comparison of results and a pre-
tested extraction form developed using published tools and
guidance. This random sample of systematic reviews was assembled
with transparent search criteria. The reporting characteristics of
these systematic reviews are given elsewhere [19]. We identified that
there was no time trend in planned or conducted subgroup analyses
across PROGRESS-Plus factors from 2004 to 2008, thus justifying
the use of this sample from November 2004.
The weaknesses of this study are that we did not assess the
availability of data on effects in vulnerable populations from the
primary studies. Three other studies have found that approxi-
mately 10% of primary studies report data disaggregated by one or
more of the PROGRESS-Plus factors [13,21,26]. We addressed
this weakness by explicitly assessing whether systematic reviews
described availability of data in primary studies. Another
limitation is that this methodology study was limited to systematic
reviews indexed in MEDLINE. Since we aimed to assess effects of
health interventions, this was an appropriate sample for our study.
However, systematic reviews in non-medical databases such as
Campbell Collaboration reviews may be more likely to assess
differences in effects across socioeconomic status because they may
focus on more upstream interventions [27,28]. This is unlikely a
serious limitation, and very unlikely to affect the conclusions of this
study. Another limitation is that we excluded non-English
systematic reviews. In two previous methods study, non-English
studies were not qualitatively or quantitatively different from
English studies in how they considered health equity or reported
results [13,21]. Thus, it is unlikely that this exclusion would affect
the conclusions of this study.
We did not assess whether subgroup analyses that were planned
were not reported or not conducted due to insufficient data or
non-statistically significant results or other factors. Thus, there
may be more equity subgroup analyses conducted that are not
statistically significant and would not have an influence on the
conclusions. In a prior study, we found that approximately half of
planned subgroup analyses were not reported in the results
(unpublished data).
Conclusions
Our findings suggest that there is inadequate consideration of
effects on health equity in systematic reviews. We propose that the
decision about whether to assess health equity needs to be
informed by the theory underlying the intervention, and that this
needs to be described in systematic reviews. Subgroup analyses are
only one way that effects on health equity can be assessed and they
are subject to spurious results and may be misleading. Applica-
bility and targeted approaches are also useful for considering
effects on health equity. The quality and completeness of reporting
should be enhanced as a priority, because without this policy-
makers and practitioners will continue lack the evidence base they
need to inform decision-making about inequity. However it is not
only about quality of reporting, it is about the fundamental need to
find a way to systematically consider impacts on equity in health
status in a way that is currently missing from systematic review
processes. The Campbell and Cochrane Equity Methods Group is
developing data-driven guidance on these methods for systematic
review authors and users.
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